FDA
-
-
-
-
-
-
-
Sintx Technologies regains Nasdaq stockholders' equity compliance
-
-
-
-
-
-
-
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
-
-
-
-
-
-
-
SINTX Technologies completes first surgery using FDA-cleared foot implant
-
-
-
-
-
-
-
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
-
-
-
-
-
-
-
SINTX Technologies reports silicon nitride shows antiviral activity
-
-
-
-
-
-
-
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors
-
-
-
-
-
-
-
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
335,005 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


